Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001593968-21-002238
Filing Date
2021-10-05
Accepted
2021-10-05 16:13:19
Documents
1
Period of Report
2021-10-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_01.html 4  
1 PRIMARY DOCUMENT primary_01.xml 4 13657
  Complete submission text file 0001593968-21-002238.txt   15020
Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Issuer) CIK: 0001771917 (see all company filings)

EIN.: 270605902 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KARUNA THERAPEUTICS, INC. 33 ARCH STREET, SUITE 3110 BOSTON MA 02110
Business Address
Miller Andrew Craig (Reporting) CIK: 0001777760 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38958 | Film No.: 211306764